🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

GSK plc

GSK Healthcare
$48.13 +$0.01 (0.02%)
Market Cap: $95.94 B
Gurus Holding
13
Popularity Rank
#158
% of Shares Held
1.17%
Net Activity (Q2 2026)
+$180.35 M

Guru Ownership Trend

Guru Analysis for GSK plc (GSK)

GSK plc (GSK), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 13 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.25 B.

Top institutional holders include Ken Fisher and Jeremy Grantham.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $180.35 M net inflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Sarah Ketterer reduced exposure by 35.5%.

Key Holders

Top 5 by Value

$1.87 B
$188.69 M
$178.94 M
$139.06 M
$26.43 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$211.84 M
Total Buy Value
New Buys 1
Additions 5
-$31.49 M
Total Sell Value
Reductions 7
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
8
Net Buyers
6

FAQs for GSK plc (GSK)

Major holders include Ken Fisher ($1.87 B), Jeremy Grantham ($188.69 M), HOTCHKIS & WILEY ($178.94 M). According to the latest reported data, 13 tracked investment managers collectively hold approximately 46.77 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $180.35 M, with 6 managers increasing positions and 8 managers reducing holdings.

During the most recent reporting period, 7 managers trimmed their positions, while 1 fully exited GSK. The total reported sell value was $31.49 M.

Yes, 1 managers opened new positions in GSK, and 5 increased their existing holdings. The total reported buy value was $211.84 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.56% Add 3.5% 35,722,792 $1.87 B Q2 2026
0.42% Add 2.2% 3,599,521 $188.69 M Q2 2026
0.52% Reduce -2.0% 3,413,574 $178.94 M Q2 2026
0.15% New Buy 2,652,881 $139.06 M Q2 2026
0.11% Reduce -27.8% 504,171 $26.43 M Q2 2026
0.01% Add 22.3% 346,157 $18.15 M Q2 2026
0.19% Add 17.8% 277,309 $14.64 M Q2 2026
3.51% Reduce -5.2% 92,383 $4.84 M Q2 2026
0.32% Reduce -0.3% 81,527 $4.27 M Q2 2026
0.19% Reduce -1.3% 27,181 $1.42 M Q2 2026
0.00% Add 30.2% 24,507 $1.28 M Q2 2026
0.01% Reduce -1.5% 24,046 $1.26 M Q2 2026
0.00% Reduce -35.5% 7,163 $375,470 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form